State: Rheinland-Pfalz

One Partner – many Opportunities. Midas Pharma is a mid-sized pharmaceutical company, founded 1988 and based in Ingelheim, Germany. Midas offers products, services and expertise along the entire pharmaceutical value chain – from Starting Materials and Active Pharmaceutical Ingredients to market-ready Finished Products and Devices. Since over three decades the family-owned company has successfully contributed to the Pharma sector and has step by step expanded its competencies. With more than 270 employees and 10 locations in all major pharmaceutical markets worldwide Midas Pharma has excellent local know-how, local contacts and well-established networks in different pharmaceutical sectors. Visit Midas Pharma at the German Pavilion and www.midas-pharma.com | Accelerate your development of Biologics and Drug Device Combinations and benefit from the experience and comprehensive pharmaceutical support to safeguard your project executions – from pre-clinic to commercial phase. Benefit from our experience and our wide-ranging portfolio, from cell-line development, CDMO, QM, RA, PV, QP, MA holder and supply chain management service, to complete your projects. Resilience your supply chains with our broad portfolio of biopharmaceutical ingredients and drug substances from R&D to commercial supply, as natural & unnatural Amino-acids, building blocks for Nucleic Acids (Nucleotides, Cap-analogues and Phosphoramidites) as well as Linkers & Payloads for drug conjugates. Ask us also about our customized solutions. Multiply your licensing opportunities for innovative developments. | Where innovation meets expertise – Midas Pharma is your all-in-one provider for biopharma Accelerate your development of Biologics and Drug Device Combinations and benefit from our expertise and tailored pharmaceutical support to safeguard your project executions – from drug discovery to commercial phase. Focus on your specific demands, whether it’s optimizing capacity or importing your product into the European Union, by using our pharma infrastructure: EU QP release services (in-house QPs), regulatory support incl. marketing authorization holdership and pharmacovigilance services (in-house EU-QPPV). Exploit our wholesale and supply chain expertise to import, launch and distribute your biopharmaceutical products. Speed up your drug discovery and development with our comprehensive bioanalytical services for mAbs, ADCs, peptides, and nucleic acids. We offer a wide range of cutting-edge analytical methods, e.g., for structural and functional characterization of proteins, lead & clone selection, and biosimilar studies. Resilience your supply chain with our broad portfolio of biopharmaceutical intermediates (Building blocks for TIDES, Linkers & Payloads etc.), produced at GMP-compliant sites. Discover Gx Inbeneo®, our next generation autoinjector, which addresses the challenges of subcutaneous self-administration of biopharmaceuticals with injection volumes of up to 3 ml and ultra-high viscosities. The constantly pre-pressurized system ensures smooth continuous injection with shortened injection times; a needle that is not in contact with the drug product prevents needle clogging. Gx Inbeneo® offers quick customization to different formulations for faster time-to-market. Midas Pharma advantages: – All-in-one provider with modular service offers, tailored to your needs – Collaboration from expert to expert – EU headquartered, with a global operational footprint | With more than 35 years of experience, Midas Pharma brings proven expertise to every stage of the biopharmaceutical product life cycle. As a fully-fledged pharmaceutical company with EU GMP/GDP/WDA and MIA licenses, we offer a complete and reliable infrastructure tailored to your needs, whether you are an innovative start-up or an established biopharmaceutical company. Combining scientific expertise with a robust global network, Midas Pharma delivers integrated end-to-end solutions that accelerate your path from early-stage R&D to market. We provide the insight, infrastructure, and commitment needed to achieve your goals with confidence and to succeed in the competitive biopharmaceutical landscape. Your key benefits: • Process development: Expertise in biotechnological and chemical processes, covering preclinical development to commercial manufacturing. • Analytical services: Comprehensive structural and functional analysis that delivers precise insights into your molecule; tailored solutions, aligning technical accuracy with strategic goals through a holistic approach. • Starting materials, intermediates, drug substance, drug product, fill and finish (non GMP and GMP quality): Robust supply chain, including documentation in compliance with the authority requirements worldwide. • Novel autoinjector platform: Innovative solutions that overcome key challenges in subcutaneous delivery – enabling the injection of small and large volumes, especially but not only for high concentrated biologics. • GMP services: From EU QP release to global import/export: guaranteeing your products meet all regulatory standards. • Market entry strategy: Guidance through the process of entering target markets, including due diligence and clinical trials. • Business Development Advisory Services: With our global network spanning mid‑ and top‑tier biopharma in the US, Europe, and Asia, we deliver expert advisory support to accelerate your partnering success. Our customized services include financial modeling and valuation, deal structuring, due diligence, partner identification, and contract negotiation empowering you to maximize shareholder value. • Commercial operations: Comprehensive wholesale solutions along with marketing authorization holder (MAH) and pharmacovigilance (PV) services. Analytical services powered by Biofidus – A member of the Midas Group